“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...

The National Institutes of Health has canceled funding for at least 383 clinical trials in the last year, affecting some ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

"I wasn't going to let Jenna die," said her mom, Kim Teachman. This week, the family starts a landmark treatment by expert Dr ...

A new technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay. It’s called the ‘Ion ...

Cancer patients who travel to Spokane for treatment will soon have a dedicated place to stay during their care, thanks to a ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

Radiation therapy treatment for breast cancer not only improves survival rates but also generates long-term financial ...

Complex digital images of tissue samples that can take an experienced pathologist up to 20 minutes to annotate could be ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...